Cell Culture Media Market Rises as Biopharma R&D and Cell Therapy Demand Accelerate

An assortment of amino acids, vitamins, inorganic salts, glucose, and serum—a source of growth factors, hormones, and attachment factors—make up a standard cell culture media. Sterile reagents, media supplements, and cell culture medium are examples of cell culture reagents. Antibiotics and supplements containing amino acids are common cell culture reagents. The serum, which is a complicated mixture of growth hormones, growth inhibitors, and albumins, is arguably one of the most crucial parts of a medium for cell culture. The most widely used serum is called fetal bovine serum (FBS). In addition to acting as a carrier for lipids, enzymes, micronutrients, and trace elements into the cell, serum controls the permeability of cell membranes.

cell culture experiments are widely used in biomedical research, regenerative medicine, and biotechnological production. Due to restrictions on the use of laboratory animals by animal protection laws and the strict implementation of the 3Rs (Replacement, Reduction, and Refinement) formulated by William Russell and Rex Burch to improve the welfare of animals, it can be expected that the general use of cell lines will further increase during the next years to substitute animal-based research [1]. However, it should be noted that cell culture experiments, when not properly conducted, are prone to errors. Therefore, cell culture studies must be performed with good cell culture practice (GCCP) to ensure the reproducibility of in vitro experimentation.

Download Your Free PDF Sample: Unlock Key Market Insights @ https://cognizancemarketresearch.com/request/cell-culture-media-sera-and-reagents-market/

Global Cell Culture Media, Sera, and Reagents Market-Competitive Insights

On March 22, 2022, FUJIFILM Irvine Scientific acquired Shenandoah Biotechnology. The deal would help the company to provide customers with a single point of access for their life science research, discovery, and cell and gene therapy needs.

On January 20, 2022, Cytiva and Nucleus Biologics LLC collaborated to enhance custom cell media development for cell and gene therapies.

Some of the Key Players in the Global Cell Culture Media, Sera, and Reagents Market Include –

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Cytiva (Danaher Corporation)
  • Becton
  • Dickinson and Company
  • Corning Incorporated
  • HiMedia Laboratories
  • FUJIFILM Irvine Scientific, Inc.
  • InvivoGen
  • SeraCare (LGC Clinical Diagnostics, Inc.)
  • Lonza

Global Cell Culture Media, Sera, and Reagents Market – Growth Drivers

The market is growing due to several factors, including an increase in the prevalence of cancer, a rise in the adoption of cell culture techniques, a rise in studies on cell biology and cytology, a surge in the demand for targeted drug therapy treatments, and an increase in the demand for personalized medicines. Furthermore, the market is growing due to several factors, including the burden of complex infectious diseases, the development of novel vaccines as a result of advancements in proteomic gene expression, the increased demand for newer 3D cell culturing techniques, the rise in R&D activities to launch novel cancer treatment procedures, and the aggressive development strategies of key market players.

Global Cell Culture Media, Sera, and Reagents Market -Restraints

The Cell Culture Media, Sera, and Reagents Market faces certain restraints despite its growth potential. One significant restraint is the high cost associated with cell culture products, which can limit accessibility and adoption, particularly in smaller research facilities or developing regions. Another challenge is the complexity and variability of cell culture systems, which can lead to inconsistencies in results and hinder standardization across different laboratories and research settings.  Additionally, ethical concerns related to the use of animal-derived sera in cell culture media pose a restraint, driving the demand for alternative, serum-free culture systems.

Download Free PDF: Sample Our Market Research @ https://cognizancemarketresearch.com/request/cell-culture-media-sera-and-reagents-market/

Global Cell Culture Media, Sera, and Reagents Market -Opportunities

There are several uses for cell culture in research on HIV/AIDS, cancer, and other infectious diseases, as well as in diagnostic and prognostic studies. The threat of new virus epidemics has grown due to several variables, including population growth, climate change, and more human-animal contact.  In 2020, cancer was the primary cause of mortality worldwide, accounting for 9.96 million fatalities. Globally, GLOBOCAN predicts that by 2040, there will be about 30 million instances of cancer. This condition is becoming more common, which means that in-depth research is required for both diagnosis and therapy. Consequently, this creates opportunities for the advancement of cell culture technologies and cell culture medium products.

Global Cell Culture Media, Sera, and Reagents Market-Geographical Insights

In terms of region, the global cell culture media, sera, and reagents market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. From 2021 to 2031, North America is anticipated to lead the global market. Approximately one-third of the worldwide biopharmaceutical market is accounted for by the United States, which also leads the world in biopharmaceutical research and development. Over half of global R&D is carried out by American companies, according to the Pharmaceutical Research and Manufacturers Association (PhRMA).In North America, this fuels the need for reagents, sera, and cell culture media. The primary drivers of cell culture’s expansion in North America are the rising demand for media free of animal components and automated systems. Furthermore, the region’s recent cell culture industry reforms regarding the use of human-derived media agents in cell culture are anticipated to stimulate market expansion.

Global Cell Culture Media, Sera, and Reagents Market– key development

  • On January 27, 2021, Thermo Fisher announced the launch of a T-cell medium. This medium is designed to culture healthy donor cells for further use in cell therapies.
  • On July 31, 2020, Corning launched its 3D clear tissue clearing reagent. This reagent can be used for in-vitro 3D cell culture models such as speroids, organoids, and microtissues.
  • On October 23, 2019, Thermo Fisher announced the launch of cell culture media. This media remains stable when stored at room temperature and can be used to promote cell growth by providing nutrients to cells.